Despite the fact that serum ISM1 levels exhibited high specificity (100%) in identifying RA patients with remission or low disease activity, the sensitivity was comparatively low (38.9%) at the proposed cut-off value. The gene discussed is ISM1; the disease is rheumatoid arthritis.